期刊文献+

血管紧张素Ⅱ通过活性氧调控ACE和ACE2的表达 被引量:4

Angiotensin Ⅱ Regulates the Expression of ACE and ACE2 via Reactive Oxygen Species
原文传递
导出
摘要 目的研究血管紧张素II(Angiotensin II,Ang II)是否通过活性氧(Reactive oxygen species,ROS)调控人肾小管上皮细胞(Human kidney tubular epithelial cell line,HK-2)中血管紧张素转换酶(Angiotensin I converting enzyme,ACE)及血管紧张素转换酶2(Angiotensin I converting enzyme 2,ACE2)的表达。方法首先给予HK-2细胞不同浓度的Ang II刺激以检测ACE及ACE2表达的变化;然后给予细胞不同浓度的Ang II,在不同时间点,用2'7'-二氯双乙酸盐(2'7'-Dichlorofluorescin diacetate,DCFH)标记结合细胞内的ROS,流式细胞仪检测ROS水平;最后,我们给予细胞ROS抑制剂二苯基氯化碘(diphenyleneiodonium chloride,DPI),分别检测ROS、ACE及ACE2的表达。结果Ang II诱导肾小管上皮细胞内ACE表达上调,ACE2表达下调。另外,Ang II会引起细胞内ROS产生增多,且与刺激浓度和刺激时间相关。DPI能抑制Ang II诱导的ROS产生,并且抑制Ang II对ACE及ACE2的调控作用。结论 Ang II通过诱导人肾小管上皮细胞产生ROS从而调控ACE以及ACE2的表达。 Objective To study whether angiotensin Ⅱ regulates the expression of angiotensin I converting enzyme via ROS in human kidney tubular epithelial cells (HK-2). Methods HK-2 cells were stimulated by different concentration of Ang Ⅱ to detect the expression of ACE and ACE2. Then the HK-2 cells were managed by Ang Ⅱ with different concentration and time and production of ROS were detected by flow cytometry. Finally HK-2 cells were pretreated by DPI, an inhibitor of ROS, 30 min before treatment orAng Ⅱ to detect the production of ROS, ACE and ACE2, respectively. Results Ang Ⅱ induces HK-2 cells to up-regulate the expression of ACE and down-regulate the expression of ACE2, meanwhile, it induces cells to produce more ROS at a dose and time dependent manner. DPI can inhibit the Ang Ⅱ-mediated regulation of ROS, ACE and ACE2. Conclusions These results indicate that angiotensin Ⅱ might regulate the expression of ACE and ACE2 in HK-2 cells via ROS.
出处 《中国分子心脏病学杂志》 CAS 2015年第2期1288-1291,共4页 Molecular Cardiology of China
基金 国家自然科学基金(81322002)
关键词 血管紧张素II 血管紧张素转换酶 血管紧张素转换酶2 ROS Angiotensin Ⅱ Angiotensin I converting enzyme (ACE) Angiotensin I converting enzyme 2 (ACE2) Reactive oxygen species (ROS)
  • 相关文献

参考文献13

  • 1李镒冲,王丽敏,姜勇,李晓燕,张梅,胡楠.2010年中国成年人高血压患病情况[J].中华预防医学杂志,2012,46(5):409-413. 被引量:438
  • 2Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications, ttypertension. 1994, 23:531-550.
  • 3Guyton AC. Kidneys and fluids in pressure regulation. Small volume but large pressure changes. Hypertension. 1992, 19:12 18.
  • 4Te Riet L, van Esch JH, Roks AJ, et al. Hypertension:Renin- Angiotensin-aldosterone system alterations. CircRes. 2013, 116(6):960-975.
  • 5Zeymer U, Dechend R, Riemer T, et al. 1-Year outcomes of hypertension management in 13,000 outpatients under practice conditions: prospective 3A registry, lnt J Cardiol. 2014, 176(3):589- 594.
  • 6Sampaio WO, Henrique de CC, Santos RA, et al. Angiotensin-(1 7) counterregulates angiotensin II signaling in human endothelial cells. ltypertension. 2007, 50:1093-1098.
  • 7Prathapan A, Vineetha VP, Raghu KG. Protective Effect ofBoerhaavia diffusa L. against Mitochondrial Dysfunction in Angiotensin II Induced Hypertrophy in H9c2 Cardiomyoblast Cells. PLoS One. 2014, 9(4):e96220.
  • 8Zhang Y, Zhang Y, Kou J, et al. Role of reactive oxygen species in angiotensin II: induced receptor activator of nuclear factor-kB ligand expression in mouse osteoblastic ceils. Mol Cell Biochem. 2014. 396(1-2):249-55.
  • 9Liang Xiao, Karla K. V. Haack, Irving H. Zucker, et al. Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen- activated protein kinase and extracellular signal-regulated kinase 1/2 signaling. Am J Physiol Cell Physiol. 2013, 304:1073-1079.
  • 10Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin- converting enzyme-related carboxypeptidase (ACE2) convertsangiotensin I to angiotensin 1-9. Circ Res. 2000,87:El-E9.

二级参考文献15

  • 1胡建平,饶克勤,钱军程,吴静.中国慢性非传染性疾病经济负担研究[J].中国慢性病预防与控制,2007,15(3):189-193. 被引量:159
  • 2王建生,姜垣,金水高.2002年我国高血压的疾病负担分析[J].中国慢性病预防与控制,2007,15(3):194-196. 被引量:71
  • 3Ezzati M, Lopez AD, Rodgers A, et al. Comparative quantification of health risks: the global and regional burden of disease attributable to selected major risk factors. Washington(DC) :world bank, 2006.
  • 4Wu Y, Huxley R, Li L, et al. Prevalence, awareness, treatment, and control of hypertension in China : data from the China National Nutrition and Health Survey 2002. Circulation, 2008,118 ( 25 ) : 2679 -2686.
  • 5中国疾病预防控制中心慢性非传染性疾病预防控制中心.中围慢性病及其危险因素监测分析报告(2004).北京:中国协和医科大学出版社,2009.
  • 6中国疾病预防控制中心慢性非传染性疾病预防控制中心.中国慢性病及其危险因素监测分析报告(2007).北京:人民卫生出版社,2010.
  • 7Bonny A, Lacombe F, Yitemben M, et al. The 2007 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens, 2008,26 ( 4 ) : 825-826.
  • 8Li H, Meng Q, Sun X, et al. Prevalence, awareness, treatment, and control of hypertension in rural China: results from Shandong Province. J Hypertens, 2010,28 ( 3 ) : 432 -438.
  • 9中华人民共和国卫生部.2010年我国卫生事业发展统计公报I EB/OL]. ( 2011-04-29 ) 12011-124)2 ]. http://www, moh. gov. cn/ publiefiles/business / htnflfiles / mohwsbwstjxxzx / s 7 9 6 7 / 2 01 104 / 51512. htm.
  • 10连祥卿.城市化与健康[J].医学与社会,2010,23(6):39-39. 被引量:5

共引文献437

同被引文献41

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部